Detrol
Utilized to manage overactive bladder symptoms to support bladder control.
Strengths: 1 · 2mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Detrusitol
- Therapeutic class
Muscarinic Receptor Antagonist
- Pharmacological class
Anticholinergic
- Minor side effects
dry mouth; dyspepsia; headache; constipation
- Moderate side effects
somnolence; blurred vision; urinary tract infection; dry eyes
- Dosage forms
Film-coated tablet; Prolonged-release capsule, hard
- Administration route
Oral use
- Patient summary
Utilized to manage overactive bladder symptoms to support bladder control.
- Prescription status
POM
- Manufacturer
Pfizer
- Onset Time
1–2 hours
- Duration
12–24 hours
- Storage instructions
Store at room temperature in a cool, dry place away from light.
- Drug interactions
other anticholinergics; potassium; metoclopramide
- Age restrictions
Not recommended for children.
Contraindications
urinary retention; uncontrolled angle-closure glaucoma; severe hepatic impairment; hypersensitivity to tolterodine
Precautions and warnings
use with caution in elderly patients; monitor for gastrointestinal motility issues; caution in patients with existing heart rhythm disorders
Serious side effects
anaphylaxis — requires immediate medical attention; angioedema — requires immediate medical attention
Mechanism of action
Blocks cholinergic receptors at the bladder neuroeffector site, reducing detrusor muscle contractions to stabilize bladder function and reduce urgency.
Pregnancy and breastfeeding
Pregnancy: Information is limited; consult your doctor. Breastfeeding: Not recommended, as the medicine may transition into breast milk.
Detrol
Utilized to manage overactive bladder symptoms to support bladder control.
Editorial Notes
- Active ingredient(s): Tolterodine
- Listed indication(s): Overactive Bladder
Usually available as
- 60 tablets - 1 mg191-1-mg-2694
- 60 tablets - 2 mg191-2-mg-1019